Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The goal of this clinical study is to test how well the study drug, obeldesivir (formerly GS-5245), works and how safe it is in treating coronavirus disease 2019 (COVID-19) in participants that have a higher risk of getting a serious illness.
Epistemonikos ID: 50e9b3cb9893b7d663bf4f6812cebc2b4ae06c46
First added on: Nov 03, 2022